Neuropathologies in Transgenic Mice Expressing Human Immunodeficiency Virus Type 1 Tat Protein under the Regulation of the Astrocyte-Specific Glial Fibrillary Acidic Protein Promoter and Doxycycline
- 1 May 2003
- journal article
- Published by Elsevier in The American Journal of Pathology
- Vol. 162 (5) , 1693-1707
- https://doi.org/10.1016/s0002-9440(10)64304-0
Abstract
No abstract availableKeywords
This publication has 90 references indexed in Scilit:
- Human Immunodeficiency Virus Tat Protein Induces Interleukin 6 mRNA Expression in Human Brain Endothelial Cells via Protein Kinase C- and cAMP-Dependent Protein Kinase PathwaysAIDS Research and Human Retroviruses, 1998
- Control of Memory Formation Through Regulated Expression of a CaMKII TransgeneScience, 1996
- Doxycycline-mediated quantitative and tissue-specific control of gene expression in transgenic mice.Proceedings of the National Academy of Sciences, 1996
- Protection against HIV-1 gp120-induced brain damage by neuronal expression of human amyloid precursor protein.The Journal of Experimental Medicine, 1995
- Development of Lymphoid Hyperplasia in Transgenic Mice Expressing the HIVtatGeneAIDS Research and Human Retroviruses, 1995
- Normal and pathological expression of GFAP promoter elements in transgenic miceGlia, 1994
- Synergistic effects of HIV coat protein and NMDA receptor-mediated neurotoxicityNeuron, 1991
- T‐lymphocyte entry into the central nervous systemJournal of Neuroscience Research, 1991
- Growth and neuroendocrine dysfunction in children with acquired immunodeficiency syndromeThe Journal of Pediatrics, 1990
- Cellular uptake of the tat protein from human immunodeficiency virusCell, 1988